TCL Archive Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described July 25, 1975
TCL Archive NCI Program: reports Urges Expansion of Surveillance Program To Better Explain Trends April 30, 1999
TCL Archive Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL December 27, 2013
TCL Archive Fox Chase Cancer Center Board Selects Michael Seiden of Dana-Farber/Harvard As New President. March 23, 2007
TCL Archive Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test August 5, 1977
TCL Archive Cancer Groups Fear Clinical Trials Coverage Will Not Be Implemented Across Exchanges July 3, 2013
